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ABSTRACT
Objective: Studies have reported high prevalence of left ventricular hypertrophy (LVH) among patients 
with microalbuminuria. Both left ventricular hypertrophy and microalbuminuria (MA) are associated 
with increased risk of cardiovascular morbidity and mortality. The study aimed to determine the predictive 
value of spot urine albumin-to-creatinine ratio (ACR) for echocardiography-based LVH in newly 
diagnosed hypertensive patients.
2 2Methods: LVH was defined as left ventricular mass index (LVMI) of >115g/m in males and >95g/m  in 
females. Microalbuminuria was defined as ACR >30 mg/g and diagnostic value of MA for LVH assessed 
2using X  2by2 table and the Receiver Operating Characteristics (ROC) curve plot.
Results: Sixty six (48.5%) males and 70(51.5%) females with a mean age of 44.8(10.5 %) years were 
studied. Left ventricular hypertrophy was observed in 36.8% while 42.7% had MA. The prevalence of MA 
in those with LVH was 66%. Microalbuminuria showed a sensitivity of 64% and specificity of 70% for 
echocardiography (echo) detected LVH, while the positive predictive value (PPV) and negative predictive 
value (NPV) were 55% and 77% respectively. Diagnostic accuracy of MA for echo LVH was 68% with an 
odd ratio of 4.1. ROC curve plot revealed an area under the curve of 0.73 at ACR of 36mg/g, improving the 
sensitivity and NPV to 85.7% and 83.8% respectively.
Conclusion: Microalbuminuria predicts LVH in treatment naïve Nigerian hypertensive patients. This 
can be used as a surrogate for LVH in outpatient settings, providing vital information for 
comprehensive management of patients.
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Valeur prédictive de spot urine albumine-de-rapport créatinine pour 
échocardiographie basée hypertrophie ventriculaire gauche entre 
nouvellement diagnostiqués chez les patients hypertendus.
1 2 1 3 4 1 1




les patients ayant une microalbuminurie. Les deux hypertrophie ventriculaire gauche et une
microalbuminurie (MA) sont associées à un risque accru de mortalité et la morbidité d'origine 
cardiovasculaire. Pour déterminer la valeur prédictive des spots urines albumine-de-rapport créatinine 
(ACR) pour échocardiographie-basée à HVG nouvellement diagnostiqués chez les patients hypertendus.
Méthodes: HVG était défini comme masse ventriculaire gauche indice (LVMI) de >115g/m chez les 
hommes et > 95 g/m chez les femmes. Microalbuminurie était définie comme ACR >30 mg/g et la valeur 
de diagnostic de la MA de HVG aévalué en utilisant X2 2by2 le tableau et le récepteur caractéristiques 
d'exploitation(courbe ROC) tracé.
Résultats: Soixante-six ( 48,5 %) hommes et 70 ( 51,5 %) étaient des filles avec une moyenne d'âge de 
44,8 ( 10,5 ) ans ont été étudiés. Hypertrophie ventriculaire gauche a été observée à 36,8 % tandis que 42,7 
% avaient MA. La prévalence de la MA dans ceux avec HVG était de 66 %. Microalbuminurie a montré 
une sensibilité de 64 % et la spécificité de 70% pour l'écho détecté HVG, tandis que la valeur predictive 
positive (VPP) et valeur prédictive négative (NPV) étaient de 55% et 77% respectivement. Précision du 
diagnostic de MA pour echo HVG était de 68 % avec une étrange ratio de 4,1. Courbe ROC tracé a révélé
une aire sous la courbe de 0,73 à ACR de 36mg/g, l'amélioration de la sensibilité et la valeur predictive 
négative de 85,7 % et 83,8 % respectivement.
Conclusion: Microalbuminurie prédit HVG en traitement nigérian naïfs patients hypertendus. Ceci peut
être utilisé comme un substitut des HVG dans les consultations ambulatoires, fournissant des
informations vitales pour la gestion globale des patients.
Mots clés: hypertension artérielle, une microalbuminurie, albumine-rapport créatinine, hypertrophie 
ventriculaire gauche.
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INTRODUCTION
Hypertension remains a leading 
cause of cardiovascular morbidity and 
mortality through its impact on the heart, 
kidney, vasculature and the brain (1). 
Indicators of hypertension-related end-organ 
damage include left ventricular hypertrophy 
(LVH), increased intima-media thickness 
and increased urinary albumin excretion (2). 
Microalbuminuria (MA) is an early clinical 
expression of hypertensive nephropathy and 
a n  i m p o r t a n t  p r o g n o s t i c a t o r  o f  
cardiovascular and renal diseases (3).
Studies have reported a high 
prevalence of LVH using echocardiography 
(echo) amongst hypertensive individuals 
with MA, indicating that the two develop in 
parallel (3). Both LVH and MA are associated 
with increased risk of all-cause mortality, 
cardiovascular disease (CVD) morbidity and 
mortality, and deterioration of renal function 
in patients with diabetes and hypertension 
(4). In line with the concept of total 
cardiovascular risk assessment in individuals 
with hypertension, guidelines on evaluation 
and  management  o f  hyper tens ion  
recommend routine screening for MA in all 
subjects with hypertension, the metabolic 
syndrome, and those with high normal blood 
pressure (5, 6).
We sought to determine the 
predictive value of MA, defined using spot 
urine albumin-creatinine-ratio (ACR) for 
echo-based LVH among newly diagnosed 
hypertensive patients.
MATERIALS AND METHODS
This was a cross-sectional study in 
which one hundred and thirty six newly 
diagnosed hypertensive patients aged 23 to 
65 years were consecutively recruited from 
the cardiology clinic of the University of 
Maiduguri Teaching Hospital from June 
2007 through February 2008. Excluded from 
the study are those with overt proteinuria 
(using conventional dipstick urinalysis), 
haematuria, glycosuria,  presence of nitrite 
on dipstick urinalysis, diabetes mellitus, 
impaired renal function (defined as a 
eGFR<90ml/min), valvular heart disease, 
cardiac failure, pregnancy, athletic/sporting 
background, use of antihypertensive 
medication, suboptimal image quality on 
Echo and refusal of consent . 
Relevant clinical history was 
obtained using a pre-validated questionnaire. 
Weight was measured with the subjects light-
clothed and height without shoes or head 
2gear. Body mass index (BMI) in Kg/m  was 
calculated from weight in kilograms divided 
2
by square of the height (in m ) and body 
surface area (BSA) was determined using the 
0.425 0.725
formula, BSA= (W xH ) x 0.007184 (7). 
Blood pressure was measured using a 
mercury sphygmomanometer after a five 
minute rest in the sitting position with the arm 
and back supported. The cuff was inflated 
above the systolic blood pressure (SBP) as 
determined by palpation of the brachial pulse 
and gradually deflated at the rate of 
2mmHg/sec. Systolic blood pressure was 
recorded as the cuff pressure corresponding 
with the appearance of the first Korotkoff 
sound (phase 1), while diastolic blood 
pressure (DBP) was taken as the cuff pressure 
corresponding with disappearance of the 
Korotkoff sound (phase 5). Measurements 
were repeated twice at five minutes interval 
and the average recorded as the patients' 
blood pressure. Hypertension was defined as 
an average blood pressure of ≥140mmHg 
systolic and/or ≥90mmHg diastolic taken on 
two separate occasions (5, 6).
Transthoracic echocardiography was 
performed on all subjects by the lead author 
using Scanner 250 (PIE Medical, Japan). 
Echocardiographic measurements were 
carried out using the leading-edge-to-leading 
edge convention (8). Left ventricular mass 
(LVM) was determined as LVM = 0.8 x 
3{1.04[(LVID  + PWT  + SWT )  – d d d
3(LVID ) ]}+ 0.6g where LVID and PWT is d d d 
left ventricular internal dimension and 
posterior wall thickness in diastole, while 
SWT is septal wall thickness in diastole. Left d 
ventricular mass index (LVMI) was 
determined as LVM divided by BSA and 
2 
LVH defined as LVMI >115g/m in males and 
Res. J. of Health Sci. Vol 3(1). January/March 2015                                                 15
Albumin/creatinine ratio in ventricular hypertrophy                              Talle M A, et. al. 
2
> 95g/m  in females (8).
Spot urine sample was collected from 
each patient on the day of echocardiography 
and urine creatinine concentration (µmol/L) 
determined using the routine Jaffe reaction 
(9).Urine albumin concentration was 
determined using mALB antibody reagent 
and assay buffer by RANDOX (MA-2426, 
RANDOX laboratories Ltd. United 
Kingdom). Spot urine albumin-to-creatinine 
ratio (ACR) in mg/g was obtained by 
dividing urine albumin concentration in 
mg/dl by the urine creatinine concentration in 
g/dl. Microalbuminuria was defined as ACR 
of 30 to 300 mg/g (10).
Statistical analyses were performed 
using SPSS (version 14.0 software, Chicago, 
IL, USA). The ACR was log transformed for 
the parametric analyses. A Chi-square 2 by 2 
contingency table was used in determining 
sensitivity, specificity, positive predictive 
value (PPV), negative predictive value 
(NPV), odds ratios, likelihood ratios and 
diagnostic accuracy of spot urine ACR for 
echo-determined LVH. Multiple regression 
analysis was used in determining the 
predictors of LVH. A p-value of ≤ 0.05 was 
considered significant.
Approval for this study was granted 
by the Research and Ethics Committee of the 
University of Maiduguri Teaching Hospital 
(UMTH). All subjects granted an informed 
consent before enrolment into the study.
RESULTS
The subjects were made of 66 
(48.5%) males and 70 (51.5%) females with a 
mean age of 44.8 (SD 10.5) years. Mean 
systolic and diastolic blood pressures were 
161.4 (SD 18.8) mmHg and 98.1 (10.00) 
mmHg respectively. The mean LVM was 
181.01 (SD 66.09)g, whilst the mean LVMI 
2was 100.47 (SD 33.78) g/m . The prevalence 
of LVH was 36.8%. The overall prevalence of 
MA was 42.7%, increasing to 66% amongst 
those with LVH. A strong positive correlation 
was observed between ACR and both LVM 
(p=0.001, r=0.773) and LVMI (p=0.001, 
r=0.414). Multiple regression analysis 
revealed SBP, pulse rate and ACR to be 
significant independent predictors of LVH.
Microa lbuminur ia  showed a  
sensitivity of 64% (95% CI: 0.60 – 0.80) and 
specificity of 70% (95% CI: 0.66 – 0.88) for 
echo-detected LVH, while the PPV and NPV 
were 55% (95% CI: 0.42 – 0.68) and 77% 
(95% CI: 0.66 – 0.87) respectively. The 
diagnostic accuracy of MA for echo-detected 
LVH was 68% (95% CI: 0.61 – 0.76) with an 
odds ratio of 4.1 (95% CI: 1.07 – 7.13), 
(Table 1). The discriminating value of ACR 
for echo detected LVH using the receiver 
operating characteristic (ROC) curve plot 
revealed an area under the curve of 0.73 at 
ACR of 36mg/g, improving the sensitivity 
and NPV to 85.7% and 83.8% respectively 
(Fig. 1). 
DISCUSSION
We have demonstrated in this study 
that spot urine ACR predicts echo-based 
LVH in t reatment  naïve Nigerian 
hypertensive subjects. To our knowledge, 
this is the first study evaluating the diagnostic 
usefulness of single void, spot urine ACR for 
echo detected LVH in newly diagnosed 
Nigerian hypertensive patients.
The prevalence of 36.8% for LVH in 
our study compares to what was reported in 
other parts of Nigeria (11, 12, 13). However, 
higher prevalence was recorded for MA 
compared to other workers (14). Odili and 
Okeahialam reported a prevalence of 36% in 
200 newly diagnosed hypertensive patients 
using micral strips, while Salako e.t al. found 
a prevalence of 37% using 24-hour urine 
collection (13, 15). These differences could 
be due to variation in methods of detecting 
MA.
The predictive values of ACR for 
LVH compares to findings among 
hypertensive patients reported by other 
workers. Post et al reported a NPV and PPV 
of 77% and 58% respectively, among young 
hypertensive African-American men (16). 
Similarly, the MAGIC study showed a NPV 
and PPV of 76% and 69% (17). However, 
comparison with the latter is not feasible, 
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given the fact they used a cut-off point of 
11.5mg/g for defining MA. In addition, 
studies have indicated that blacks have a 
higher propensity to have albuminuria 
compared to whites, the population studied in 
the MAGIC study (17, 18, 19). This assertion 
is corroborated by our study since decreasing 
the diagnostic cut-off value to 11.5mg/g as 
used in the MAGIC study would translate 
into higher prevalence of MA. 
The independent predictive value of 
ACR for LVH is in keeping with reports of 
other workers, depicting the parallel 
development  of  MA and LVH in 
hypertensive subjects. Jensen et al reported 
the first prospective study on the predictive 
roles of MA in the development of 
cardiovascular events in a 10-year follow-up 
of 204 untreated hypertensive subjects (20). 
The LIFE study reported a higher frequency 
and degree of MA in hypertensive patients 
with greater LVM independent of SBP, age, 
race or co-existing diabetes (21). In the 
MAGIC study, higher prevalence of 
electrocardiographic LVH was reported in 
patients with elevated urinary albumin 
excretion rate (17). Similarly, Tsioufis et al 
found that hypertensive subjects with MA 
exhibited higher incidence of unfavorable LV 
geometric patterns compared to those 
without (22). Our findings of SBP and pulse 
rate as independent predictors of LVH 
contrasted with that of Salako et al where 
only SBP was significantly related to LVH 
(13).
The mechanisms leading to increased 
cardiovascular morbidity and mortality in 
patients with microalbuminuria are not fully 
understood. Albuminuria has been linked to 
risk factors for atherosclerosis including 
hypertension, aging and diabetes mellitus 
(23). This could be a reflection of 
microvascular injury in the glomeruli and 
vasculature, with increased lipid insudation 
and atherogenesis. This provides the 
substrate for thrombosis in the cerebral and 
coronary vessels leading to increased 
cardiovascular morbidity and mortality (24). 
Left ventricular hypertrophy sets the stage 
for diastolic dysfunction, myocardial 
ischaemia and arrhythmogenesis, resulting in 
increased CV morbidity and mortality (25).
Urinary ACR and LVH are adjudged 
to be predictors of cardiovascular death, non-
fatal stroke and non-fatal myocardial 
infarction (26).Given the greatest risk 
associated with hypertensive TOD, and the 
potential benefit of early intervention, 
guidelines recommends screening for LVH 
and MA in patients with hypertension (5,6). 
Assessment of MA using the spot urine ACR 
can be easily carried out during out-patient 
consultation to serve as a surrogate for LVH 
where echo is not readily available. 
The limitations of this study include 
the relatively small sample size and the use of 
single void urine sample rather than multiple 
urine specimens, given the fact that albumin 
excretion is variable. Excluding urinary tract 
infection on the basis of dipstick nitrite alone, 
might not be conclusive since not all 
organisms causing urinary tract infection 
produce nitrite.
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Table 1: Diagnostic value of microalbuminuria for left ventricular hypertrophy
 
    
ACR>30mg/g
    
95% CI
 
Sensitivity 0.64 0.53 – 0.79
Specificity 0.70 0.60 – 0.80
PPV
      
0.55






      
0.77






      
2.13






      
0.52 






      
4.10





ACR=albumin-to-creatinine ratio; CI=Confidence interval; PPV=Positive predictive 
value; NPV=Negative predictive value; LR+=Positive likelihood ratio; LR- =Negative 









1: Receiver Operating Characteristics curve for diagnostic value of Albumin - to -
Creatinine Ratio (ACR) for left ventricular hypertrophy.
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